A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial
Authors:
- Anissa AharazAAAnissa Aharaz
- Jens Henning RasmussenJRJens Henning Rasmussen
- Helle Bach Ølgaard McNultyHMHelle Bach Ølgaard McNulty
- Arne CyronACArne Cyron
- Pia Keinicke FabriciusPFPia Keinicke Fabricius
- Anne Kathrine BengaardABAnne Kathrine Bengaard
- Hayley Rose Constance SejbergHSHayley Rose Constance Sejberg
- Rikke Rie Løvig SimonsenRSRikke Rie Løvig Simonsen
- Charlotte TreldalCTCharlotte Treldal
- Morten Baltzer HoulindMHMorten Baltzer Houlind
Open Access
- 30 March 2021
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 11 (4) , 204
Abstract
Medication deprescribing is essential to prevent inappropriate medication use in multimorbid patients. However, experience of deprescribing in Danish Subacute Medical Outpatient Clinics (SMOCs) is limited. The objective of our pilot study was to evaluate the feasibility and sustainability of a collaborative deprescribing intervention by a pharmacist and a physician to multimorbid patients in a SMOC. A randomized controlled pilot study was conducted, with phone follow-up at 30 and 365+ days. A senior pharmacist performed a systematic deprescribing intervention using the Screening Tool of Older Persons’ potentially inappropriate Prescriptions (STOPP) criteria, the Danish deprescribing list, and patient interviews. A senior physician received the proposed recommendations and decided which should be implemented. The main outcome was the number of patients having ≥1 medication where deprescribing status was sustained 30 days after inclusion. Out of 76 eligible patients, 72 (95%) were included and 67 (93%) completed the study (57% male; mean age 73 years; mean number of 10 prescribed medications). Nineteen patients (56%) in the intervention group and four (12%) in the control group had ≥1 medication where deprescribing status was sustained 30 days after inclusion (p = 0.015). In total, 37 medications were deprescribed in the intervention group and five in the control group. At 365+ days after inclusion, 97% and 100% of the deprescribed medications were sustained in the intervention and control groups, respectively. The three most frequently deprescribed medication groups were analgesics, cardiovascular, and gastrointestinal medications. In conclusion, a collaborative deprescribing intervention for multimorbid patients was feasible and resulted in sustainable deprescribing of medication in a SMOC.Keywords
This publication has 43 references indexed in Scilit:
- Medication Reviews by Clinical Pharmacists at Hospitals Lead to Improved Patient Outcomes: A Systematic ReviewBasic & Clinical Pharmacology & Toxicology, 2013
- Soluble Urokinase Plasminogen Activator Receptor is Associated With Inflammation in the Vulnerable Human Atherosclerotic PlaqueStroke, 2012
- Shared Decision Making — The Pinnacle of Patient-Centered CareNew England Journal of Medicine, 2012
- Acceptance and importance of clinical pharmacists’ LIMM-based recommendationsInternational Journal of Clinical Pharmacy, 2012
- Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisitsEuropean Journal of Clinical Pharmacology, 2011
- The Effect of Systematic Medication Review in Elderly Patients Admitted to an Acute Ward of Internal MedicineBasic & Clinical Pharmacology & Toxicology, 2010
- A multi‐intervention approach on drug therapy can lead to a more appropriate drug use in the elderly. LIMM‐Landskrona Integrated Medicines ManagementJournal of Evaluation in Clinical Practice, 2009
- Clinical update: adverse effects of antiretroviral therapyThe Lancet, 2007
- Effect of a Collaborative Approach on the Quality of Prescribing for Geriatric Inpatients: A Randomized, Controlled TrialJournal of the American Geriatrics Society, 2007
- Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinicEuropean Journal of Clinical Pharmacology, 2006